Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor

Genes and Development

Volumn 16, Issue 24, 2002, Pages 3199-3212

  Lee, Changwook ^a   Chang, Jeong Ho ^a   Lee, Hyun Sook ^b   Cho, Yunje ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Crystal structure; E2F 2; Rb; Transactivation

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

A BOX; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; B BOX; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CRYSTAL STRUCTURE; ENZYME MODIFICATION; HOMEOBOX; HUMAN; HUMAN CELL; MAMMAL; MITOSIS INHIBITION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; REPRESSOR GENE; RETINOBLASTOMA; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

CELL CYCLE PROTEINS; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F2 TRANSCRIPTION FACTOR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RETINOBLASTOMA PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; SURFACE PLASMON RESONANCE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 0037115601     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1046102     Document Type: Article

References (74)

1. Bagchi, S., Weinmann, R., and Raychaudhuri, P. 1991. The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65: 1063-1072.
2. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., and Wiley, D.C. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512.
3. Blake, M.C. and Azizkhan, J.C. 1989. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9: 4994-5002.
4. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J., and Kouzarides, T. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.
5. Brunger, A.T., Adams, P.D., Clore, G.M., Delano, W.L., Gros, P., Grosse-Kunstieve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., and Pannu, N.S. 1998. Crystallography & NMR system: A new software suit for macromolecular structure determination. Acta Crystallogr. D 54: 905-921.
6. Chellappan, S.F., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W.C., and Nevins, J.R. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. 89: 4549-4553.
7. Collaborative Computational Project. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50: 760-763.
8. Cress, W.D., Johnson, D.G., and Nevins, J.R. 1993. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol. Cell. Biol. 13: 6314-6325.
9. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11: 1797-1804.
10. DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.M., and Livingston, D.M. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085-1095.
11. DeGregori, J., Kowalik, T., and Nevins, J.R. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
12. Dou, Q.P., Markell, P.J., and Pardee, A.B. 1992. Thymidine kinase transcription is regulated at G1/S phase by a complex that contains retinoblastoma-like protein and a cdc2 kinase. Proc. Natl. Acad. Sci. 89: 3256-3260.
13. Dynlacht, B.D. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389: 149-152.
14. Dynlacht, B.D., Flores, O., Lees, J.A., and Harlow, E. 1994. Differential regulation of E2F trans-activation by cyclin-cdk2 complexes. Genes & Dev. 8: 1772-1786.
15. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes & Dev. 12: 2245-2262.
16. Ezhevsky, S.A., Nagahara, H., Vocero-Akbani, A.M., Gius, D.R., Wei, M.C., and Dowdy, S.F. 1997. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:CDK4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. 20: 699-704.
17. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin Jr., W.G., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. 1996. E2F-1 functions in mice to prompt apoptosis and suppress proliferation. Cell 85: 549-561.
18. Flemington, E.K., Speck, S.H., and Kaelin, W.G. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. 90: 6914-6918.
19. Freedman, S.J., Sun, Z.Y., Poy, F., Kung, A.L., Livingston, D.M., Wagner, G., and Eck, M.J. 2002. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 α. Proc. Natl. Acad. Sci. 99: 5367-5372.
20. Fry, C.J., Pearson, A., Malinowski, E., Bartley, S.M., Greenblatt, J., and Farnham, P.J. 1999. Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J. Biol. Chem. 274: 15883-15991.
21. Furukawa, Y., Terui, Y., Sakoe, K., Ohta, M., and Saito, M. 1994. The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J. Biol. Chem. 269: 26249-26258.
22. Guo, Z., Yikang, S., Yoshida, H., Mak, T.W., and Zacksenhaus, E. 2001. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61: 8395-8400.
23. Hagemeier, C., Cook, A., and Kouzarides, T. 1993. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21: 4998-5004.
24. Harbour, J.W. and Dean, D.C. 2000a. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes & Dev. 14: 2393-2409.
25. -. 2000b. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2: 65-67.
26. Harbour, J.W., Luo, R.X., Dei Santi, A., Postigo, A.A., and Dean, D.C. 1999. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cell move through G1. Cell 98: 859-869.
27. Helin, K., Lees, J.A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 33-50.
28. Helin, K., Harlow, E., and Fattaey, A. 1993a. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13: 6501-6508.
29. Helin, K., Wu, C.L., Fattaey, A.R., Lees, J.A., Dynlacht, B.D., Ngwu, C., and Harlow, E. 1993b. Heterodimerization of the transcription factor E2F-1 and DP-1 leads to cooperative trans-activation. Genes & Dev. 7: 1850-1861.
30. Hiebert, S.W., Lipp, M., and Nevins, J.R. 1989. E1A-dependent trans-activation of the human MYC prompter is mediated by the E2F factor. Proc. Natl. Acad. Sci. 86: 3594-3598.
31. Hiebert, S.W., Chellappan, S.P., Horowitz, J.M., and Nevins, J.R. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes & Dev. 6: 177-185.
32. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., van'tVeer, L.J., and Bernards, R. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15: 3082-3089.
33. Hu, Q.J., Dyson, N., and Harlow, E. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9: 1147-1155.
34. Huang, S., Wang, N.P., Tseng, B.Y., Lee, W.H., and Lee, E.H. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9: 1815-1822.
35. Ikeda, M.A., Jakoi, L., and Nevins, J.R. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. 93: 3215-3220.
36. Irwin, M., Marin, M.C., Phillips, A.C., Seelan, R.S., Smith, D.I., Liu, W., Flores, E.R., Tsai, K.Y., Jacks, T., Vousden, K.H., et al. 2000. Role for p53 homologue p73 in E2F-1-induced apoptosis. Nature 407: 645-648.
37. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110-119.
38. Kaelin Jr., W.G., Ewen, M.E., and Livingston, D.M. 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10: 3761-3769.
39. Kaelin Jr., W.G., Krek, W., Sellers, W.R., DeCaprio, J.A., Ajchenbaum, F., Fuchs, C.S., Chittenden, T., Li, Y., Farnham, P.J., Blanar, M.A., et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351-364.
40. Kim, H.-Y., Ahn, B.Y., and Cho, Y. 2001. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J. 20: 295-304.
41. Kratzke, R.A., Otterson, G.A., Hogg, A., Coxon, A.B., Geradts, J., Cowell, J.K., and Kaye, F.J. 1994. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9: 1321-1326.
42. Krek, W., Livingston, D.M., and Shirodkar, S. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262: 1557-1560.
43. Kussie, P.H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A.J., and Pavletich, N.P. 1996. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953.
44. Lee, C. and Cho, Y. 2002. Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor. Rev. Med. Virol. 12: 81-92.
45. Lee, J.A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., and Helin, K. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813-7825.
46. Lee, J.-O., Russo, A.A., and Pavletich, N.P. 1998. Structure of the retinoblastoma tumor-suppressor pocket domain bound to a peptide from HPV E7. Nature 391: 859-865.
47. Ludlow J.W., Shon, J., Pipas, J.M., Livingston, D.M., and DeCaprio, J.A. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60: 387-396.
48. Lundberg, A.S. and Weinberg, R.A. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18: 753-761.
49. Luo, R.X., Postigo, A.A., and Dean, D.C. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-473.
50. Meador, W.E., Means, A.R., and Quiocho, F.A. 1992. Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science 257: 1251-1255.
51. Moberg, K., Starz, M.A., and Lees, J.A. 1996. E2F4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16: 1436-1449.
52. Mudryi, M., Hiebert, S.W., and Nevins, J.R. 1990. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9: 2179-2184.
53. Nevins, J.R. 2001. The Rb/E2F pathway and cancer. Hum. Mol. Gen. 10: 699-703.
54. Nielsen, S.J., Schneider, R., Bauer, U.M., Bannister, A.J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R.E., et al. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561-565.
55. Onadim, Z., Hogg, A., Baird, P.N., and Cowell, J.K. 1992. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc. Natl. Acad. Sci. 89: 6177-6181.
56. Otwinowski, Z. and Minor, W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326.
57. Pearson, A. and Greenblatt, J. 1997. Modular organization of the E2F activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene 15: 2643-2658.
58. Pearson, B.E., Nasheuer, H.P., and Wang, T.S. 1991. Human DNA polymerase α gene: Sequences controlling expression in cycling and serum-stimulated cells. Mol. Cell. Biol. 11: 2081-2095.
59. Pierce, A.M., Gimenz-Conti, I.B., Schneider-Broussard, R., Martinez, L.A., Conti, C.J., and Johnson, D.G. 1998. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. 95: 8858-8863.
60. Radhakrishnan, I., Perez-Alvarado, G.C., Parker, D., Dyson, H.J., Montminy, M.R., and Wright, P.E. 1997. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: A model for activator: Coactivator interactions. Cell 91: 741-752.
61. Ross, J.F., Liu, X., and Dynlacht, B.D. 1999. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell 3: 195-205.
62. Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen-Durr, P., and Henglein, B. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. 92: 11264-11268.
63. Shan, B., Durfee, T., and Lee, W.H. 1996. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. 93: 679-684.
64. Templeton, D.J., Park, S.H., Lanier, L., and Weinberg, R.A. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. 88: 3033-3037.
65. Thalmeier, K., Synovzik, H., Mertz, R., Winnacker, E.L., and Lipp, M. 1989. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes & Dev. 3:527-536.
66. Trouche, D. and Kouzarides, T. 1996. E2F1 and E1A 12S have a homologous activation domain regulated by RB and CBP. Proc. Natl. Acad. Sci. 93: 1439-1442.
67. Trouche, D., Cook, A., and Kouzarides, T. 1996. The CBP coactivator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24:4139-4145.
68. Uesugi, M., Nyanguile, O., Lu, H., Levine, A.J., and Verdine, G.L. 1997. Induced α helix in the VP16 activation domain upon binding to a human TAF. Science 277: 1310-1313.
69. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
70. Weintraub, S.J., Chow, K.N., Luo, R.X., Zhang, S.H., He, S., and Dean, D.C. 1995. Mechanism of active transcriptional repression by the retinoblastoma proteins. Nature 375: 812-815.
71. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N.J. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
72. +/- mice. Nat. Genet. 18: 360-364.
73. INK4a, TGFβ, and contact inhibition. Cell 97: 53-61.
74. Zhang, H.S., Gavin, M., Dahiya, A., Postigo, A.A., Ma, D., Luo, R.X., Harbour, J.W., and Dean, D.C. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101: 79-89.